Gabitril fails to improve GAD symptoms in three controlled trials Carlat Reports

Gabitril fails to improve GAD symptoms in three controlled trials

The Carlat Psychiatry Report, Volume 6, Number 9, September 2008
https://www.thecarlatreport.com/newsletter-issue/tcprv6n9/

From The Carlat Psychiatry Report, September 2008, Treating Personality Disorders

Issue Links: Learning Objectives | Editorial Information

Topics: Anxiety Disorder

Section editor, Glen Spielmans, PhD

Cephalon’s selective GABA reuptake inhibitor, the antiepileptic drug tiagabine (Gabitril), was assessed for the treatment of generalized anxiety disorder in adults in three large 10-week placebo-controlled studies.

You can't view details of this content, please login or buy subscription here

Section editor, Glen Spielmans, PhD

Glen Spielmans, PhD, has disclosed that he has no relevant financial or other interests in any commercial companies ertaining to this educational activity.